Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15 - Rocca, Y S; Roberti, M P; Juliá, E P (Front Immunol, 2016)
doi:10.3389/fimmu.2016.00413